Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation
► Phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is involved in Tat-induced NADPH oxidase stimulation. ► NF-κB nuclear translocation in Tat-treated MAGI cells is dependent on Nox2 activation. ► Akt/NADPH oxidase pathway is involved in Tat-induced LTR transactivation in MAGI cells. Human...
Saved in:
Published in | Archives of biochemistry and biophysics Vol. 505; no. 2; pp. 266 - 272 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
15.01.2011
|
Subjects | |
Online Access | Get full text |
ISSN | 0003-9861 1096-0384 1096-0384 |
DOI | 10.1016/j.abb.2010.10.018 |
Cover
Abstract | ► Phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is involved in Tat-induced NADPH oxidase stimulation. ► NF-κB nuclear translocation in Tat-treated MAGI cells is dependent on Nox2 activation. ► Akt/NADPH oxidase pathway is involved in Tat-induced LTR transactivation in MAGI cells.
Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR) transactivation. However, the intracellular mechanisms whereby Tat triggers ROS production, and the relationship between Tat-induced ROS production and LTR transactivation, are still subject to debate. The present study was undertaken to evaluate the specific effects of Tat on nicotinamide adenine denucleotide phosphate (NADPH) oxidase in MAGI cells, and to determine the specific role of NADPH oxidase in Tat-induced LTR transactivation. Application of Tat to MAGI cells caused increases in ROS formation that were prevented by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2, but not by other inhibitors of pro-oxidant enzymes or siRNA Nox4. Furthermore, inhibition of NADPH oxidase by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2 attenuated Tat-induced p65 phosphorylation and IKK phosphorylation. Phosphatidylinositol 3-kinase/Akt signaling pathway was involved in Tat-induced NADPH oxidase stimulation. Finally, NADPH oxidase inhibitors or Nox2 siRNA, but not control siRNA, inhibited Tat-induced LTR transactivation. Tat-induced HIV-1 LTR transactivation was inhibited in wortmannin or LY294002 treated cells compared to control cells. Together, these data describe a specific and biologically significant signaling component of the MAGI cells response to Tat, and suggest the PI3K/Akt signaling pathway might originate in part with Tat-induced activation of NADPH oxidase and LTR transactivation. |
---|---|
AbstractList | Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR) transactivation. However, the intracellular mechanisms whereby Tat triggers ROS production, and the relationship between Tat-induced ROS production and LTR transactivation, are still subject to debate. The present study was undertaken to evaluate the specific effects of Tat on nicotinamide adenine denucleotide phosphate (NADPH) oxidase in MAGI cells, and to determine the specific role of NADPH oxidase in Tat-induced LTR transactivation. Application of Tat to MAGI cells caused increases in ROS formation that were prevented by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2, but not by other inhibitors of pro-oxidant enzymes or siRNA Nox4. Furthermore, inhibition of NADPH oxidase by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2 attenuated Tat-induced p65 phosphorylation and IKK phosphorylation. Phosphatidylinositol 3-kinase/Akt signaling pathway was involved in Tat-induced NADPH oxidase stimulation. Finally, NADPH oxidase inhibitors or Nox2 siRNA, but not control siRNA, inhibited Tat-induced LTR transactivation. Tat-induced HIV-1 LTR transactivation was inhibited in wortmannin or LY294002 treated cells compared to control cells. Together, these data describe a specific and biologically significant signaling component of the MAGI cells response to Tat, and suggest the PI3K/Akt signaling pathway might originate in part with Tat-induced activation of NADPH oxidase and LTR transactivation. Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR) transactivation. However, the intracellular mechanisms whereby Tat triggers ROS production, and the relationship between Tat-induced ROS production and LTR transactivation, are still subject to debate. The present study was undertaken to evaluate the specific effects of Tat on nicotinamide adenine denucleotide phosphate (NADPH) oxidase in MAGI cells, and to determine the specific role of NADPH oxidase in Tat-induced LTR transactivation. Application of Tat to MAGI cells caused increases in ROS formation that were prevented by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2, but not by other inhibitors of pro-oxidant enzymes or siRNA Nox4. Furthermore, inhibition of NADPH oxidase by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2 attenuated Tat-induced p65 phosphorylation and IKK phosphorylation. Phosphatidylinositol 3-kinase/Akt signaling pathway was involved in Tat-induced NADPH oxidase stimulation. Finally, NADPH oxidase inhibitors or Nox2 siRNA, but not control siRNA, inhibited Tat-induced LTR transactivation. Tat-induced HIV-1 LTR transactivation was inhibited in wortmannin or LY294002 treated cells compared to control cells. Together, these data describe a specific and biologically significant signaling component of the MAGI cells response to Tat, and suggest the PI3K/Akt signaling pathway might originate in part with Tat-induced activation of NADPH oxidase and LTR transactivation.Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR) transactivation. However, the intracellular mechanisms whereby Tat triggers ROS production, and the relationship between Tat-induced ROS production and LTR transactivation, are still subject to debate. The present study was undertaken to evaluate the specific effects of Tat on nicotinamide adenine denucleotide phosphate (NADPH) oxidase in MAGI cells, and to determine the specific role of NADPH oxidase in Tat-induced LTR transactivation. Application of Tat to MAGI cells caused increases in ROS formation that were prevented by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2, but not by other inhibitors of pro-oxidant enzymes or siRNA Nox4. Furthermore, inhibition of NADPH oxidase by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2 attenuated Tat-induced p65 phosphorylation and IKK phosphorylation. Phosphatidylinositol 3-kinase/Akt signaling pathway was involved in Tat-induced NADPH oxidase stimulation. Finally, NADPH oxidase inhibitors or Nox2 siRNA, but not control siRNA, inhibited Tat-induced LTR transactivation. Tat-induced HIV-1 LTR transactivation was inhibited in wortmannin or LY294002 treated cells compared to control cells. Together, these data describe a specific and biologically significant signaling component of the MAGI cells response to Tat, and suggest the PI3K/Akt signaling pathway might originate in part with Tat-induced activation of NADPH oxidase and LTR transactivation. ► Phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is involved in Tat-induced NADPH oxidase stimulation. ► NF-κB nuclear translocation in Tat-treated MAGI cells is dependent on Nox2 activation. ► Akt/NADPH oxidase pathway is involved in Tat-induced LTR transactivation in MAGI cells. Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR) transactivation. However, the intracellular mechanisms whereby Tat triggers ROS production, and the relationship between Tat-induced ROS production and LTR transactivation, are still subject to debate. The present study was undertaken to evaluate the specific effects of Tat on nicotinamide adenine denucleotide phosphate (NADPH) oxidase in MAGI cells, and to determine the specific role of NADPH oxidase in Tat-induced LTR transactivation. Application of Tat to MAGI cells caused increases in ROS formation that were prevented by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2, but not by other inhibitors of pro-oxidant enzymes or siRNA Nox4. Furthermore, inhibition of NADPH oxidase by both pharmacologic NADPH oxidase inhibitors and by siRNA Nox2 attenuated Tat-induced p65 phosphorylation and IKK phosphorylation. Phosphatidylinositol 3-kinase/Akt signaling pathway was involved in Tat-induced NADPH oxidase stimulation. Finally, NADPH oxidase inhibitors or Nox2 siRNA, but not control siRNA, inhibited Tat-induced LTR transactivation. Tat-induced HIV-1 LTR transactivation was inhibited in wortmannin or LY294002 treated cells compared to control cells. Together, these data describe a specific and biologically significant signaling component of the MAGI cells response to Tat, and suggest the PI3K/Akt signaling pathway might originate in part with Tat-induced activation of NADPH oxidase and LTR transactivation. |
Author | Zhang, Hong-Sheng Wang, Yu-Ou Sang, Wei-Wei Ruan, Zheng |
Author_xml | – sequence: 1 givenname: Hong-Sheng surname: Zhang fullname: Zhang, Hong-Sheng email: zhanghs@bjut.edu.cn – sequence: 2 givenname: Wei-Wei surname: Sang fullname: Sang, Wei-Wei – sequence: 3 givenname: Zheng surname: Ruan fullname: Ruan, Zheng – sequence: 4 givenname: Yu-Ou surname: Wang fullname: Wang, Yu-Ou |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21029719$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1uGyEUhVGVqHHSPkA3Fbumi7G5zAww6iqNmh_JSqXKyRYxwKS4M4wD2G1erQ_RZyqOk00X7ga46DvnSuccowM_eovQOyBTIMBmy6lq2yklT_OUgHiFJkAaVpBSVAdoQggpi0YwOELHMS4JAagYfY2OKBDacGgmaDj7kWY34y86u7ko_vz-jKO796p3_h6vVPr-Uz1iF7Hzm7HfWJMfeKFS4bxZ6zxeXd8VgPsx08mGwWUlDnZlVcKn88W3jzgF5aPSyW1UcqN_gw471Uf79vk-QbcXXxbnV8X86-X1-dm80BWIVGhTEmGIAQHAjaIMmgpq1YHoKOfKaqi6yuaDVV3X1qylZWOMgZY3LWU1KU_Qh53vKowPaxuTHFzUtu-Vt-M6SlHWAIzXNJOne0nglFQlz-v_jxJKRF2XbIu-f0bX7WCNXAU3qPAoX3LPAN8BOowxBttJ7dJTRDkx12cvuW1YLmVuWG4b3n7lhrMS_lG-mO_TfNppbM5842yQUTvrc4MuWJ2kGd0e9V_hYbvB |
CitedBy_id | crossref_primary_10_3390_ijms222010977 crossref_primary_10_1016_j_febslet_2015_11_033 crossref_primary_10_3390_biology1030668 crossref_primary_10_1242_jcs_123653 crossref_primary_10_1016_j_biocel_2012_11_002 crossref_primary_10_1002_rmv_2240 crossref_primary_10_1016_j_bbamcr_2012_02_014 crossref_primary_10_1016_j_biocel_2016_09_016 crossref_primary_10_1111_acel_12308 crossref_primary_10_1002_jcp_24552 crossref_primary_10_1016_j_biomag_2014_02_006 crossref_primary_10_1186_1742_2094_8_123 crossref_primary_10_1016_j_abb_2017_05_018 crossref_primary_10_1073_pnas_2020152118 crossref_primary_10_3389_fcimb_2022_827717 crossref_primary_10_1016_j_lfs_2012_03_013 crossref_primary_10_1093_jleuko_qiac011 crossref_primary_10_3390_cimb46080523 crossref_primary_10_1016_j_cytogfr_2015_09_001 |
Cites_doi | 10.1128/JVI.02074-06 10.1177/135965350901400109 10.1021/bi902022n 10.1038/nrd2336 10.1371/journal.ppat.0020130 10.1146/annurev.med.53.082901.104024 10.1016/j.antiviral.2009.09.014 10.1002/eji.200737854 10.1016/0891-5849(95)00047-2 10.1016/j.chom.2008.10.004 10.1074/jbc.M704481200 10.1007/s00018-002-8520-9 10.1089/ars.2008.2097 10.1038/sj.emboj.7600900 10.1099/vir.0.016303-0 10.1186/1742-4690-4-52 10.1074/jbc.274.41.28837 10.1038/nri2674 10.1038/cr.2009.137 10.1097/00002030-200317004-00003 10.1186/1742-4690-4-56 10.1016/j.ijrobp.2006.02.040 10.1016/S1054-3589(07)55004-0 10.1016/j.cell.2008.07.032 10.1016/j.virol.2007.02.004 10.1101/gad.1228704 10.1016/S0891-5849(99)00107-0 10.1128/JVI.00599-07 10.1126/science.1152725 10.1016/j.micinf.2005.06.003 10.1128/JVI.75.18.8524-8537.2001 10.1093/nar/28.3.663 10.1128/JVI.66.4.2232-2239.1992 10.1073/pnas.95.23.13519 10.1016/j.virusres.2009.08.005 10.1038/sj.emboj.7601248 10.1006/clim.1999.4831 10.1002/j.1460-2075.1995.tb07030.x 10.1016/j.chom.2008.04.001 10.1016/S1074-7613(00)80326-X 10.1002/j.1460-2075.1995.tb07141.x 10.1016/j.freeradbiomed.2009.04.028 10.1002/j.1460-2075.1993.tb06029.x 10.1074/jbc.M200007200 |
ContentType | Journal Article |
Copyright | 2010 Elsevier Inc. Copyright © 2010 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2010 Elsevier Inc. – notice: Copyright © 2010 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7U9 H94 7S9 L.6 7X8 |
DOI | 10.1016/j.abb.2010.10.018 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Virology and AIDS Abstracts AIDS and Cancer Research Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Virology and AIDS Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | AGRICOLA AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1096-0384 |
EndPage | 272 |
ExternalDocumentID | 21029719 10_1016_j_abb_2010_10_018 S0003986110004534 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -DZ -~X .~1 0R~ 1B1 1RT 1~. 1~5 23M 4.4 457 4G. 5GY 5VS 6J9 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABFRF ABGSF ABJNI ABMAC ABPPZ ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACNCT ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DM4 DOVZS EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA HLW HZ~ IH2 IHE J1W K-O KOM L7B LG5 LX2 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SDF SDG SDP SES SPCBC SSU SSZ T5K TWZ WH7 ~02 ~G- .55 .GJ .HR 3O- 53G AAHBH AAQXK AATTM AAXKI AAYWO AAYXX ABEFU ABFNM ABWVN ACRPL ACVFH ADCNI ADFGL ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGHFR AGQPQ AGRDE AGRNS AHHHB AI. AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CAG CITATION COF FEDTE FGOYB G-2 HVGLF MVM NEJ OHT R2- SBG SEW SSH UQL VH1 WUQ X7M XOL XPP YYP ZGI ZMT ZXP ~KM CGR CUY CVF ECM EIF NPM 7U9 EFKBS H94 7S9 L.6 7X8 |
ID | FETCH-LOGICAL-c418t-cd308d0d18117da2619415af18f277aec14f4e14f64ffb56b239ddd1b79b26503 |
IEDL.DBID | AIKHN |
ISSN | 0003-9861 1096-0384 |
IngestDate | Fri Sep 05 06:34:17 EDT 2025 Thu Sep 04 22:59:50 EDT 2025 Fri Sep 05 07:53:36 EDT 2025 Thu Apr 03 07:08:48 EDT 2025 Tue Jul 01 03:47:57 EDT 2025 Thu Apr 24 23:11:05 EDT 2025 Fri Feb 23 02:17:47 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | HIV-1 LTR transactivation Akt Tat Nox2 |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2010 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c418t-cd308d0d18117da2619415af18f277aec14f4e14f64ffb56b239ddd1b79b26503 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 21029719 |
PQID | 1020855365 |
PQPubID | 23462 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_835116752 proquest_miscellaneous_1720437415 proquest_miscellaneous_1020855365 pubmed_primary_21029719 crossref_citationtrail_10_1016_j_abb_2010_10_018 crossref_primary_10_1016_j_abb_2010_10_018 elsevier_sciencedirect_doi_10_1016_j_abb_2010_10_018 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-01-15 |
PublicationDateYYYYMMDD | 2011-01-15 |
PublicationDate_xml | – month: 01 year: 2011 text: 2011-01-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Archives of biochemistry and biophysics |
PublicationTitleAlternate | Arch Biochem Biophys |
PublicationYear | 2011 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Wu, Ma, Myers, Terada (b0200) 2007; 282 Annibaldi, Sajeva, Muscolini, Ciccosanti, Corazzari, Piacentini, Tuosto (b0015) 2008; 38 McMichael, Borrow, Tomaras, Goonetilleke, Haynes (b0110) 2010; 10 Hayden, Ghosh (b0060) 2004; 18 Kim, Bourgeois, Pearson, Tyagi, West, Wong, Wu, Chiang, Karn (b0075) 2006; 25 Vignais (b0160) 2002; 59 McKinnon, Mellors, Swindells (b0105) 2009; 14 Wan, Lenardo (b0165) 2010; 20 Williams, Kwon, Chen, Greene (b0190) 2007; 81 Yan, Banerjee (b0230) 2010; 49 Brass, Dykxhoorn, Benita, Yan, Engelman, Xavier, Lieberman, Elledge (b0025) 2008; 319 Marzio, Tyagi, Gutierrez, Giacca (b0100) 1998; 95 Zhou, Xu, Huang, Gates, Zhang, Stec, Ferrer, Strulovici, Hazuda, Espeseth (b0220) 2008; 4 Pereira, Bentley, Peeters, Churchill, Deacon (b0120) 2000; 28 Ranjbar, Tsytsykova, Lee, Rajsbaum, Falvo, Lieberman, Shankar, Goldfeld (b0130) 2006; 2 Kinoshita, Su, Amano, Timmerman, Kaneshima, Nolan (b0085) 1997; 6 Strebel (b0145) 2003; 17 Coiras, Lopez-Huertas, Rullas, Mittelbrunn, Alcami (b0040) 2007; 4 Williams, Chen, Kwon, Ruiz-Jarabo, Verdin, Greene (b0185) 2006; 25 Sgarbanti, Remoli, Marsili, Ridolfi, Borsetti, Perrotti, Orsatti, Ilari, Sernicola, Stellacci, Ensoli, Battistini (b0140) 2008; 82 Konig, Zhou, Elleder, Diamond, Bonamy, Irelan, Chiang, Tu, De Jesua, Seidel, Opaluch, Caldwell, Weitzman, Kuhen, Bandyopadhyay, Ideker, Orth, Miraglia, Bushman, Young, Chanda1 (b0090) 2008; 135 Agrawal, Louboutin, Strayer (b0005) 2007; 363 Hetzer, Dormeyer, Schnolzer, Ott (b0065) 2005; 7 Alcami, Lain de Lera, Folgueira, Pedraza, Jacque, Bachelerie, Noriega, Hay, Harrich, Gaynor (b0010) 1995; 14 Zhang, Li, Zhou, Wu, Zhou (b0210) 2009; 47 Romani, Engelbrecht, Glashoff (b0135) 2010; 91 West, Lowe, Karn (b0175) 2001; 75 Blankson, Persaud, Siliciano (b0225) 2002; 53 Chen-Park, Huang, Noro, Thanos, Ghosh (b0030) 2002; 277 Cihlar, Ray (b0035) 2010; 85 Pace, Leaf (b0115) 1995; 19 Wang, Joseph (b0170) 1999; 27 Kimpton, Emerman (b0080) 1992; 66 Zhang, Wu (b0215) 2009; 146 Cron, Bartz, Clausell, Bort, Klebanoff, Lewis (b0045) 2000; 94 Sun, Huang, Xu, Wang, Bai, Sui, Zhou (b0150) 2006; 65 Lama, Planelles (b0095) 2007; 4 Turchan-Cholewo, Dimayuga, Gupta, Gorospe, Keller, Bruce-Keller (b0155) 2009; 11 Perkins, Edwards, Duckett, Agranoff, Schmid, Nabel (b0125) 1999; 12 Gatignol (b0055) 2007; 55 Westendorp, Shatrov, Schulze-Osthoff, Frank, Kraft, Los, Krammer, Droge, Lehmann (b0180) 1995; 14 Winkler (b0195) 2008; 3 Jeang, Xiao, Rich (b0070) 1999; 274 Flexner (b0050) 2007; 6 Kim (10.1016/j.abb.2010.10.018_b0075) 2006; 25 Pace (10.1016/j.abb.2010.10.018_b0115) 1995; 19 Williams (10.1016/j.abb.2010.10.018_b0190) 2007; 81 Zhang (10.1016/j.abb.2010.10.018_b0210) 2009; 47 Sun (10.1016/j.abb.2010.10.018_b0150) 2006; 65 Strebel (10.1016/j.abb.2010.10.018_b0145) 2003; 17 Agrawal (10.1016/j.abb.2010.10.018_b0005) 2007; 363 Williams (10.1016/j.abb.2010.10.018_b0185) 2006; 25 Chen-Park (10.1016/j.abb.2010.10.018_b0030) 2002; 277 Kinoshita (10.1016/j.abb.2010.10.018_b0085) 1997; 6 Wu (10.1016/j.abb.2010.10.018_b0200) 2007; 282 Vignais (10.1016/j.abb.2010.10.018_b0160) 2002; 59 Yan (10.1016/j.abb.2010.10.018_b0230) 2010; 49 McKinnon (10.1016/j.abb.2010.10.018_b0105) 2009; 14 Lama (10.1016/j.abb.2010.10.018_b0095) 2007; 4 Pereira (10.1016/j.abb.2010.10.018_b0120) 2000; 28 Wan (10.1016/j.abb.2010.10.018_b0165) 2010; 20 Brass (10.1016/j.abb.2010.10.018_b0025) 2008; 319 Cihlar (10.1016/j.abb.2010.10.018_b0035) 2010; 85 Turchan-Cholewo (10.1016/j.abb.2010.10.018_b0155) 2009; 11 Marzio (10.1016/j.abb.2010.10.018_b0100) 1998; 95 Alcami (10.1016/j.abb.2010.10.018_b0010) 1995; 14 Winkler (10.1016/j.abb.2010.10.018_b0195) 2008; 3 Gatignol (10.1016/j.abb.2010.10.018_b0055) 2007; 55 Ranjbar (10.1016/j.abb.2010.10.018_b0130) 2006; 2 Annibaldi (10.1016/j.abb.2010.10.018_b0015) 2008; 38 Hetzer (10.1016/j.abb.2010.10.018_b0065) 2005; 7 Cron (10.1016/j.abb.2010.10.018_b0045) 2000; 94 Wang (10.1016/j.abb.2010.10.018_b0170) 1999; 27 Hayden (10.1016/j.abb.2010.10.018_b0060) 2004; 18 Coiras (10.1016/j.abb.2010.10.018_b0040) 2007; 4 Jeang (10.1016/j.abb.2010.10.018_b0070) 1999; 274 West (10.1016/j.abb.2010.10.018_b0175) 2001; 75 Westendorp (10.1016/j.abb.2010.10.018_b0180) 1995; 14 Romani (10.1016/j.abb.2010.10.018_b0135) 2010; 91 Zhang (10.1016/j.abb.2010.10.018_b0215) 2009; 146 Kimpton (10.1016/j.abb.2010.10.018_b0080) 1992; 66 Flexner (10.1016/j.abb.2010.10.018_b0050) 2007; 6 Blankson (10.1016/j.abb.2010.10.018_b0225) 2002; 53 Sgarbanti (10.1016/j.abb.2010.10.018_b0140) 2008; 82 Perkins (10.1016/j.abb.2010.10.018_b0125) 1999; 12 McMichael (10.1016/j.abb.2010.10.018_b0110) 2010; 10 Konig (10.1016/j.abb.2010.10.018_b0090) 2008; 135 Zhou (10.1016/j.abb.2010.10.018_b0220) 2008; 4 |
References_xml | – volume: 6 start-page: 235 year: 1997 end-page: 244 ident: b0085 publication-title: Immunity – volume: 277 start-page: 24701 year: 2002 end-page: 24708 ident: b0030 publication-title: J. Biol. Chem. – volume: 2 start-page: e130 year: 2006 ident: b0130 article-title: NFAT 5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site publication-title: PLoS Pathog. – volume: 65 start-page: 842 year: 2006 end-page: 850 ident: b0150 publication-title: Int. J. Radiat. Oncol. Biol. Phys. – volume: 49 start-page: 1059 year: 2010 end-page: 1066 ident: b0230 publication-title: Biochemistry – volume: 85 start-page: 39 year: 2010 end-page: 58 ident: b0035 publication-title: Antiviral. Res. – volume: 82 start-page: 3632 year: 2008 end-page: 3641 ident: b0140 publication-title: J. Virol. – volume: 55 start-page: 137 year: 2007 end-page: 159 ident: b0055 publication-title: Adv. Pharmacol. – volume: 20 start-page: 24 year: 2010 end-page: 33 ident: b0165 publication-title: Cell Res. – volume: 25 start-page: 139 year: 2006 end-page: 149 ident: b0185 publication-title: EMBO J. – volume: 319 start-page: 921 year: 2008 end-page: 926 ident: b0025 publication-title: Science – volume: 274 start-page: 28837 year: 1999 end-page: 28840 ident: b0070 publication-title: Tat. J. Biol. Chem. – volume: 95 start-page: 13519 year: 1998 end-page: 13524 ident: b0100 publication-title: Proc. Natl. Acad. Sci. USA – volume: 17 start-page: S25 year: 2003 end-page: 34 ident: b0145 publication-title: AIDS – volume: 27 start-page: 612 year: 1999 end-page: 616 ident: b0170 publication-title: Free Radic. Biol. Med. – volume: 3 start-page: 203 year: 2008 end-page: 205 ident: b0195 publication-title: Cell Host Microbe. – volume: 14 start-page: 1 year: 2009 end-page: 12 ident: b0105 publication-title: Antivir. Ther. – volume: 25 start-page: 3596 year: 2006 end-page: 3604 ident: b0075 publication-title: EMBO J. – volume: 4 start-page: 52 year: 2007 ident: b0095 publication-title: Retrovirology – volume: 53 start-page: 557 year: 2002 end-page: 593 ident: b0225 publication-title: Annu. Rev. Med. – volume: 12 start-page: 3551 year: 1999 end-page: 3558 ident: b0125 publication-title: EMBO J. – volume: 363 start-page: 462 year: 2007 end-page: 472 ident: b0005 publication-title: Virology – volume: 81 start-page: 6043 year: 2007 end-page: 6056 ident: b0190 publication-title: J. Virol. – volume: 18 start-page: 2195 year: 2004 end-page: 2224 ident: b0060 publication-title: Genes Dev. – volume: 6 start-page: 959 year: 2007 end-page: 966 ident: b0050 publication-title: Nat. Rev. Drug Discov. – volume: 94 start-page: 179 year: 2000 end-page: 191 ident: b0045 publication-title: Clin. Immunol. – volume: 47 start-page: 261 year: 2009 end-page: 268 ident: b0210 publication-title: Free Radical. Biol. Med. – volume: 14 start-page: 1552 year: 1995 end-page: 1560 ident: b0010 publication-title: EMBO J. – volume: 28 start-page: 663 year: 2000 end-page: 668 ident: b0120 publication-title: Nucl. Acids Res. – volume: 91 start-page: 1 year: 2010 end-page: 12 ident: b0135 publication-title: J. Gen. Virol. – volume: 38 start-page: 1446 year: 2008 end-page: 1451 ident: b0015 publication-title: Eur. J. Immunol. – volume: 59 start-page: 1428 year: 2002 end-page: 1459 ident: b0160 publication-title: Cell Mol. Life Sci. – volume: 7 start-page: 1364 year: 2005 end-page: 1369 ident: b0065 publication-title: Microbes Infect. – volume: 146 start-page: 51 year: 2009 end-page: 57 ident: b0215 publication-title: Virus Res. – volume: 135 start-page: 49 year: 2008 end-page: 60 ident: b0090 publication-title: Cell – volume: 4 start-page: 56 year: 2007 ident: b0040 publication-title: Retrovirology – volume: 14 start-page: 546 year: 1995 end-page: 554 ident: b0180 publication-title: EMBO J. – volume: 66 start-page: 2232 year: 1992 end-page: 2239 ident: b0080 publication-title: J. Virol. – volume: 11 start-page: 193 year: 2009 end-page: 204 ident: b0155 publication-title: Antioxid. Redox Signal. – volume: 75 start-page: 8524 year: 2001 end-page: 8537 ident: b0175 publication-title: J. Virol. – volume: 10 start-page: 11 year: 2010 end-page: 23 ident: b0110 publication-title: Nat. Rev. Immunol. – volume: 19 start-page: 523 year: 1995 end-page: 528 ident: b0115 publication-title: Free Radic. Biol. Med. – volume: 282 start-page: 37412 year: 2007 end-page: 37419 ident: b0200 publication-title: J. Biol. Chem. – volume: 4 start-page: 495 year: 2008 end-page: 504 ident: b0220 publication-title: Cell Host Microbe. – volume: 81 start-page: 6043 year: 2007 ident: 10.1016/j.abb.2010.10.018_b0190 publication-title: J. Virol. doi: 10.1128/JVI.02074-06 – volume: 14 start-page: 1 year: 2009 ident: 10.1016/j.abb.2010.10.018_b0105 publication-title: Antivir. Ther. doi: 10.1177/135965350901400109 – volume: 49 start-page: 1059 year: 2010 ident: 10.1016/j.abb.2010.10.018_b0230 publication-title: Biochemistry doi: 10.1021/bi902022n – volume: 6 start-page: 959 year: 2007 ident: 10.1016/j.abb.2010.10.018_b0050 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2336 – volume: 2 start-page: e130 year: 2006 ident: 10.1016/j.abb.2010.10.018_b0130 article-title: NFAT 5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.0020130 – volume: 53 start-page: 557 year: 2002 ident: 10.1016/j.abb.2010.10.018_b0225 publication-title: Annu. Rev. Med. doi: 10.1146/annurev.med.53.082901.104024 – volume: 85 start-page: 39 year: 2010 ident: 10.1016/j.abb.2010.10.018_b0035 publication-title: Antiviral. Res. doi: 10.1016/j.antiviral.2009.09.014 – volume: 38 start-page: 1446 year: 2008 ident: 10.1016/j.abb.2010.10.018_b0015 publication-title: Eur. J. Immunol. doi: 10.1002/eji.200737854 – volume: 19 start-page: 523 year: 1995 ident: 10.1016/j.abb.2010.10.018_b0115 publication-title: Free Radic. Biol. Med. doi: 10.1016/0891-5849(95)00047-2 – volume: 4 start-page: 495 year: 2008 ident: 10.1016/j.abb.2010.10.018_b0220 publication-title: Cell Host Microbe. doi: 10.1016/j.chom.2008.10.004 – volume: 282 start-page: 37412 year: 2007 ident: 10.1016/j.abb.2010.10.018_b0200 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M704481200 – volume: 59 start-page: 1428 year: 2002 ident: 10.1016/j.abb.2010.10.018_b0160 publication-title: Cell Mol. Life Sci. doi: 10.1007/s00018-002-8520-9 – volume: 11 start-page: 193 year: 2009 ident: 10.1016/j.abb.2010.10.018_b0155 publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2008.2097 – volume: 25 start-page: 139 year: 2006 ident: 10.1016/j.abb.2010.10.018_b0185 publication-title: EMBO J. doi: 10.1038/sj.emboj.7600900 – volume: 91 start-page: 1 year: 2010 ident: 10.1016/j.abb.2010.10.018_b0135 publication-title: J. Gen. Virol. doi: 10.1099/vir.0.016303-0 – volume: 4 start-page: 52 year: 2007 ident: 10.1016/j.abb.2010.10.018_b0095 publication-title: Retrovirology doi: 10.1186/1742-4690-4-52 – volume: 274 start-page: 28837 year: 1999 ident: 10.1016/j.abb.2010.10.018_b0070 publication-title: Tat. J. Biol. Chem. doi: 10.1074/jbc.274.41.28837 – volume: 10 start-page: 11 year: 2010 ident: 10.1016/j.abb.2010.10.018_b0110 publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2674 – volume: 20 start-page: 24 year: 2010 ident: 10.1016/j.abb.2010.10.018_b0165 publication-title: Cell Res. doi: 10.1038/cr.2009.137 – volume: 17 start-page: S25 year: 2003 ident: 10.1016/j.abb.2010.10.018_b0145 publication-title: AIDS doi: 10.1097/00002030-200317004-00003 – volume: 4 start-page: 56 year: 2007 ident: 10.1016/j.abb.2010.10.018_b0040 publication-title: Retrovirology doi: 10.1186/1742-4690-4-56 – volume: 65 start-page: 842 year: 2006 ident: 10.1016/j.abb.2010.10.018_b0150 publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2006.02.040 – volume: 55 start-page: 137 year: 2007 ident: 10.1016/j.abb.2010.10.018_b0055 publication-title: Adv. Pharmacol. doi: 10.1016/S1054-3589(07)55004-0 – volume: 135 start-page: 49 year: 2008 ident: 10.1016/j.abb.2010.10.018_b0090 publication-title: Cell doi: 10.1016/j.cell.2008.07.032 – volume: 363 start-page: 462 year: 2007 ident: 10.1016/j.abb.2010.10.018_b0005 publication-title: Virology doi: 10.1016/j.virol.2007.02.004 – volume: 18 start-page: 2195 year: 2004 ident: 10.1016/j.abb.2010.10.018_b0060 publication-title: Genes Dev. doi: 10.1101/gad.1228704 – volume: 27 start-page: 612 year: 1999 ident: 10.1016/j.abb.2010.10.018_b0170 publication-title: Free Radic. Biol. Med. doi: 10.1016/S0891-5849(99)00107-0 – volume: 82 start-page: 3632 year: 2008 ident: 10.1016/j.abb.2010.10.018_b0140 publication-title: J. Virol. doi: 10.1128/JVI.00599-07 – volume: 319 start-page: 921 year: 2008 ident: 10.1016/j.abb.2010.10.018_b0025 publication-title: Science doi: 10.1126/science.1152725 – volume: 7 start-page: 1364 year: 2005 ident: 10.1016/j.abb.2010.10.018_b0065 publication-title: Microbes Infect. doi: 10.1016/j.micinf.2005.06.003 – volume: 75 start-page: 8524 year: 2001 ident: 10.1016/j.abb.2010.10.018_b0175 publication-title: J. Virol. doi: 10.1128/JVI.75.18.8524-8537.2001 – volume: 28 start-page: 663 year: 2000 ident: 10.1016/j.abb.2010.10.018_b0120 publication-title: Nucl. Acids Res. doi: 10.1093/nar/28.3.663 – volume: 66 start-page: 2232 year: 1992 ident: 10.1016/j.abb.2010.10.018_b0080 publication-title: J. Virol. doi: 10.1128/JVI.66.4.2232-2239.1992 – volume: 95 start-page: 13519 year: 1998 ident: 10.1016/j.abb.2010.10.018_b0100 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.95.23.13519 – volume: 146 start-page: 51 year: 2009 ident: 10.1016/j.abb.2010.10.018_b0215 publication-title: Virus Res. doi: 10.1016/j.virusres.2009.08.005 – volume: 25 start-page: 3596 year: 2006 ident: 10.1016/j.abb.2010.10.018_b0075 publication-title: EMBO J. doi: 10.1038/sj.emboj.7601248 – volume: 94 start-page: 179 year: 2000 ident: 10.1016/j.abb.2010.10.018_b0045 publication-title: Clin. Immunol. doi: 10.1006/clim.1999.4831 – volume: 14 start-page: 546 year: 1995 ident: 10.1016/j.abb.2010.10.018_b0180 publication-title: EMBO J. doi: 10.1002/j.1460-2075.1995.tb07030.x – volume: 3 start-page: 203 year: 2008 ident: 10.1016/j.abb.2010.10.018_b0195 publication-title: Cell Host Microbe. doi: 10.1016/j.chom.2008.04.001 – volume: 6 start-page: 235 year: 1997 ident: 10.1016/j.abb.2010.10.018_b0085 publication-title: Immunity doi: 10.1016/S1074-7613(00)80326-X – volume: 14 start-page: 1552 year: 1995 ident: 10.1016/j.abb.2010.10.018_b0010 publication-title: EMBO J. doi: 10.1002/j.1460-2075.1995.tb07141.x – volume: 47 start-page: 261 year: 2009 ident: 10.1016/j.abb.2010.10.018_b0210 publication-title: Free Radical. Biol. Med. doi: 10.1016/j.freeradbiomed.2009.04.028 – volume: 12 start-page: 3551 year: 1999 ident: 10.1016/j.abb.2010.10.018_b0125 publication-title: EMBO J. doi: 10.1002/j.1460-2075.1993.tb06029.x – volume: 277 start-page: 24701 year: 2002 ident: 10.1016/j.abb.2010.10.018_b0030 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M200007200 |
SSID | ssj0011462 |
Score | 2.0951552 |
Snippet | ► Phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway is involved in Tat-induced NADPH oxidase stimulation. ► NF-κB nuclear translocation in Tat-treated... Human immunodeficiency virus (HIV) regulatory protein Tat has pro-oxidant property, which might contribute to Tat-induced long terminal repeat region (LTR)... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 266 |
SubjectTerms | 1-Phosphatidylinositol 3-kinase adenine Akt AKT protein CYBB protein Data processing enzyme inhibition enzyme inhibitors Enzymes HeLa Cells HIV-1 HIV-1 - genetics HIV-1 - metabolism Human immunodeficiency virus 1 Humans I-kappa B Proteins - metabolism IKK protein Long terminal repeat LTR transactivation Membrane Glycoproteins - metabolism NAD(P)H oxidase NAD(P)H oxidase (H2O2-forming) NADP (coenzyme) NADPH Oxidase 2 NADPH Oxidases - metabolism NF- Kappa B protein NF-kappa B - metabolism nicotinamide Nox2 NOX4 protein Oxidative Stress Phosphatidylinositol 3-Kinase - metabolism Phosphorylation Proto-Oncogene Proteins c-akt - metabolism Reactive oxygen species Reactive Oxygen Species - metabolism regulatory proteins Signal Transduction siRNA small interfering RNA Tat tat Gene Products, Human Immunodeficiency Virus - metabolism Tat protein terminal repeat sequences Terminal Repeat Sequences - genetics Transcription Factor RelA - metabolism Transcriptional Activation Wortmannin |
Title | Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation |
URI | https://dx.doi.org/10.1016/j.abb.2010.10.018 https://www.ncbi.nlm.nih.gov/pubmed/21029719 https://www.proquest.com/docview/1020855365 https://www.proquest.com/docview/1720437415 https://www.proquest.com/docview/835116752 |
Volume | 505 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9tnRC8INj4KB-TkRACJNM4sRP3sauoOj76gDq0t8iOHanQpdWWAXvhD-OP4G_iLokrIbE-8BJZyVlyfPZ9-O78A3heFjZKjdFcljLh0hrFbaIdz5AjDjVs5gwVOH-cpdMT-e5Une7AONTCUFplJ_tbmd5I6-7NoJvNwXqxoBrfKBnqlO48Q7skkbuwF6O21z3YGx2_n842wQQUBnEAzqMOIbjZpHkZa9sEL8rxIuiPf6un68zPRg1N7sDtzn5ko3aId2HHV_twMKrQdz67Yi9Yk9HZHJXvw42j0Lo5DrhuB3A2-loPZqsf8WA24b9_HTFK4TBUlc4Invi7uWKLC7aoUG598w4bbG5qjq47LgLHpsefuWDLFVJ3eTRLdu7XKNHZyw_zT69YHQDI27Pee3AyeTsfT3kHusALKXTNC5dE2kVOUAWqM-RgoY43pdBlnGXGFwK56vGRyrK0KrU45845YbOhjdHcS-5Dr1pV_iEwp5ym_Z-UUslCFaZE3VeqWFofZ0bbPkRhrvOiu5GcgDGWeUg9-5Ije3JiD71C9vTh9abLur2OYxuxDAzM_1pTOaqLbd2eBWbnyBoKoJjKry4v8DshmqokVVtoCPUnITutD-waGk3RW_TU4j48aBfT5mfIAx9mYvjo_8b-GG61h96CC_UEevX5pX-KVlNtD2H3zU9x2O2NP0wWE80 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFD4andC4QbDBKAwwEkKAZDWJnb_LrqJKWZcL1KHdRXacSIUurbZsY6-2h9gz7ZwkroTEesFNZCW25Pizz499jj-Aj2WunUCpiMtSCi618rkWkeEhImJQw4ZGUYLzcRokJ_L7qX-6BSObC0NhlZ3sb2V6I627N4NuNAer-ZxyfB0RRwHdeYZ2iZCPYFsSqXUPtoeToyRdHyagMPAscR41sIebTZiX0roN8KIYL6L--Ld6esj8bNTQ-Bk87exHNmy7-By2imoX9oYV-s5nN-wTayI6m63yXXh8aEs7I8vrtgdnw9_1IF3-8QbpmN_dHjIK4VCUlc6Invha3bD5BZtXKLeuCoMFNlM1R9cdJ4FhyeQnd9liibW7OJoFOy9WKNHZ5-nsxxdWWwLydq_3BZyMv81GCe9IF3gu3ajmuRFOZBzjUgaqUeRgoY5XpRuVXhiqIncR1QIfgSxL7QfaE7ExxtVhrD0098RL6FXLqngFzPgmovUvSsQl93NVou4rfU_qwgtVpPvg2LHO8u5GciLGWGQ29OxXhvBkBA-9Qnj68HXdZNVex7GpsrQAZn_NqQzVxaZmHyzYGUJDByiqKpaXF_idGE19Efgb6hDrjyA7rQ_sgToRnd6ip-b1Yb-dTOufIQ88Dt349f_1_T3sJLPjaTadpEdv4Em7Ae5y1z-AXn1-WbxFC6rW77oVcg_I9BWz |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Akt%2FNox2%2FNF-%CE%BAB+signaling+pathway+is+involved+in+Tat-induced+HIV-1+long+terminal+repeat+%28LTR%29+transactivation&rft.jtitle=Archives+of+biochemistry+and+biophysics&rft.au=Zhang%2C+Hong-Sheng&rft.au=Sang%2C+Wei-Wei&rft.au=Ruan%2C+Zheng&rft.au=Wang%2C+Yu-Ou&rft.date=2011-01-15&rft.issn=0003-9861&rft.volume=505&rft.issue=2+p.266-272&rft.spage=266&rft.epage=272&rft_id=info:doi/10.1016%2Fj.abb.2010.10.018&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-9861&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-9861&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-9861&client=summon |